Luping Li1, Lei Shi2, Junjie Zhang1, Yingzhong Fan1, Qi Li2. 1. Department of Pediatric Surgery, the First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou, China. 2. Department of Urology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou, China.
Abstract
OBJECTIVE: Based on the eighth TNM staging system, T3a renal cell carcinoma (RCC) is identified as an anatomical extrarenal invasion and does not consider the size of the tumor; however, it may not fully predict the prognosis of the patient. The objective of this study was to evaluate the prognostic value of tumor size effects on prognosis in T3a RCC and propose an alternative tumor stage system combined with T1-2. METHODS: Data relating to T1-3aN0M0 RCC (n = 49586) were obtained from the Surveillance, Epidemiology, and End Results database (2004-2015). Survival analyses were conducted by Cox regression and Fine and Gray regression. Harrell's concordance index (c-index) was used to assess the discriminatory ability of the prognostic factors. RESULTS: A 1-cm increase in T3a RCC resulted in an 8% increase in all-cause mortality (hazard ratio [HR]: 1.08; 95% confidence interval [CI]: 1.06-1.10, p < 0.001) and 14% increase in the risk of RCC-specific mortality (sub-distribution HR [sHR]: 1.14; 95% CI: 1.11-1.16, p < 0.001). T3a tumor size stratified by the cutoff of 4 cm and 7 cm showed a better prediction of RCC-special survival (c-index: 0.644), compared with a cutoff just by 4 cm (c-index: 0.571) or by 7 cm (c-index: 0.602). Compared with T1b tumors, T3a RCC ≤4 cm showed no differences in terms of all-cause mortality (HR: 0.93; 95% CI: 0.79-1.09; p = 0.37) and mortality caused by RCC (sHR: 0.91; 95% CI: 0.70-1.19; p = 0.50). Last, the alternative T-staging system (T1a, a combination of T1b and T3a [≤4 cm], T2a, T2b, T3a [4-7 cm], and T3a [>7] cm) demonstrated good RCC-special survival predictive accuracy (c-index: 0.729), which was higher than that shown by the current eighth edition T-staging system (c-index: 0.720). CONCLUSION: Tumor size should be taken into consideration for T3aN0M0 RCC rather than based on anatomical features alone.
OBJECTIVE: Based on the eighth TNM staging system, T3a renal cell carcinoma (RCC) is identified as an anatomical extrarenal invasion and does not consider the size of the tumor; however, it may not fully predict the prognosis of the patient. The objective of this study was to evaluate the prognostic value of tumor size effects on prognosis in T3a RCC and propose an alternative tumor stage system combined with T1-2. METHODS: Data relating to T1-3aN0M0 RCC (n = 49586) were obtained from the Surveillance, Epidemiology, and End Results database (2004-2015). Survival analyses were conducted by Cox regression and Fine and Gray regression. Harrell's concordance index (c-index) was used to assess the discriminatory ability of the prognostic factors. RESULTS: A 1-cm increase in T3a RCC resulted in an 8% increase in all-cause mortality (hazard ratio [HR]: 1.08; 95% confidence interval [CI]: 1.06-1.10, p < 0.001) and 14% increase in the risk of RCC-specific mortality (sub-distribution HR [sHR]: 1.14; 95% CI: 1.11-1.16, p < 0.001). T3a tumor size stratified by the cutoff of 4 cm and 7 cm showed a better prediction of RCC-special survival (c-index: 0.644), compared with a cutoff just by 4 cm (c-index: 0.571) or by 7 cm (c-index: 0.602). Compared with T1b tumors, T3a RCC ≤4 cm showed no differences in terms of all-cause mortality (HR: 0.93; 95% CI: 0.79-1.09; p = 0.37) and mortality caused by RCC (sHR: 0.91; 95% CI: 0.70-1.19; p = 0.50). Last, the alternative T-staging system (T1a, a combination of T1b and T3a [≤4 cm], T2a, T2b, T3a [4-7 cm], and T3a [>7] cm) demonstrated good RCC-special survival predictive accuracy (c-index: 0.729), which was higher than that shown by the current eighth edition T-staging system (c-index: 0.720). CONCLUSION:Tumor size should be taken into consideration for T3aN0M0 RCC rather than based on anatomical features alone.
Authors: Paras H Shah; Daniel M Moreira; Vinay R Patel; Geoffrey Gaunay; Arvin K George; Manaf Alom; Zachary Kozel; Oksana Yaskiv; Simon J Hall; Michael J Schwartz; Manish A Vira; Lee Richstone; Louis R Kavoussi Journal: J Urol Date: 2017-03-06 Impact factor: 7.450
Authors: Sabine D Brookman-May; Matthias May; Ingmar Wolff; Richard Zigeuner; Georg C Hutterer; Luca Cindolo; Luigi Schips; Ottavio De Cobelli; Bernardo Rocco; Cosimo De Nunzio; Andrea Tubaro; Ioman Coman; Michael Truss; Orietta Dalpiaz; Bogdan Feciche; Robert S Figenshau; Kerry Madison; Manuel Sánchez-Chapado; Maria del Carmen Santiago Martin; Luigi Salzano; Giuseppe Lotrecchiano; Stefan Zastrow; Manfred Wirth; Petros Sountoulides; Shahrokh Shariat; Raphaela Waidelich; Christian Stief; Sven Gunia Journal: Eur Urol Date: 2015-02-13 Impact factor: 20.096
Authors: Hiury S Andrade; Homayoun Zargar; Oktay Akca; Onder Kara; Peter A Caputo; Daniel Ramirez; Guillermo Andrés; Robert J Stein; Shih-Chieh J Chueh; Jihad H Kaouk Journal: J Endourol Date: 2017-01-05 Impact factor: 2.942
Authors: Christopher M Russell; Amir H Lebastchi; Juan Chipollini; Adam Niemann; Rohit Mehra; Todd M Morgan; David C Miller; Ganesh S Palapattu; Khaled S Hafez; Wade J Sexton; Philippe E Spiess; Alon Z Weizer Journal: Urology Date: 2018-04-17 Impact factor: 2.649
Authors: Christopher J Weight; Casey Lythgoe; Raman Unnikrishnan; Brian R Lane; Steven C Campbell; Amr F Fergany Journal: Urology Date: 2011-03-21 Impact factor: 2.649
Authors: John S Lam; Tobias Klatte; Jean-Jacques Patard; Rakhee H Goel; François Guillè; Bernard Lobel; Clement-Claude Abbou; Alexandre De La Taille; Jacques Tostain; Luca Cindolo; Vincenzo Altieri; Vincenzo Ficarra; Walter Artibani; Tommaso Prayer-Galetti; Luigi Schips; Richard Zigeuner; Allan J Pantuck; Robert A Figlin; Arie S Belldegrun Journal: Eur Urol Date: 2007-02-07 Impact factor: 20.096
Authors: Alessandro Veccia; Ugo Falagario; Alberto Martini; Michele Marchioni; Alessandro Antonelli; Claudio Simeone; Luigi Cormio; Umberto Capitanio; M Carmen Mir; Ithaar Derweesh; Hendrik Van Poppel; Francesco Porpiglia; Riccardo Autorino Journal: Eur Urol Focus Date: 2020-06-19
Authors: Raimonda Kubiliūtė; Kristina Žukauskaitė; Algirdas Žalimas; Albertas Ulys; Rasa Sabaliauskaitė; Arnas Bakavičius; Arūnas Želvys; Feliksas Jankevičius; Sonata Jarmalaitė Journal: J Cancer Res Clin Oncol Date: 2021-10-23 Impact factor: 4.553